Page 32 - CIBEROBN2016-ENG

Platforms Coordinator: José Manuel Fernández-Real “FATBANK” Platform
The platform’s noteworthy accomplishments in 2016 were as follows:
• The 5 Nodes of the Platform signing the internal agreement regulating cooperation, between them, and stressing:
The legal and regulatory definition governing this.
Minimum characteristics for a donor to be able to be included in the collection. Minimum commitments of the Nodes in respect of the Platform.
Regulation of the Internal Scientific Committee.
Conditions in the event of drafting scientific articles that are published thanks to the use of samples coming from the FATBANK.
• Exhaustive review of all the information associated with the donors and samples of the coordinating node.
• Exhaustive check of storage of ALL the samples on an I.T. basis by the coordinating node.
• Starting to collect a new type of adipose tissue mode: intra-osseous adipose tissue.
muESTRAS 2016
Nodo
No Donantes acumulados 2009-2016
DONANTES 2016
SuERO
PlASmA EDTA
BuFFY COAT
TA vIS- CERAl
TA PARIETAl
TA TIROIDAl
HECES
girona
464
78
1280
2528
616
70
69
22
239
málaga
199
32
0
0
0
0
0
0
0
Pamplona
277
75
205
782
133
132
43
0
0
Santiago
153
28
328
852
166
54
27
0
0
Córdoba
88
0
0
0
0
0
0
0
0
Total
1181
213
1813
4162
915
256
139
22
239
Metagenomics Platform
The Metagenomics Platform is a system shared by the IBIMA and the CIBEROBN. In the first six months of 2016 the tender and acquisition of the structure took place. The use of the platform is being managed by the CIBEROBN research group led by Dr Tinahones and forms part of the ECAI (Common Support Structures for Research) in genomics of the IBIMA.
From October 2016 the technical staff working at the platform were given training by the Thermo Fisher Scientific (company in charge of installing the equipment).
In December 2016 the platform was already operative and the analyses of the following projects started:
• Analysis of the samples of stools of patients undergoing bariatric surgery, comparing responders and non-responders (cooperative study with CIBERDEM, Hospital Clinic Dr. Pep Vidal’s group).
• Analysis of samples of the of cooperation agreement with Pronakal company. Intervention with high- calorie, high-protein diet with and without added probiotic.
1323